Masimo Corporation (NASDAQ:MASI) has received an average recommendation of “Hold” from the nine brokerages that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $97.00.

MASI has been the subject of several recent research reports. Roth Capital increased their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. Zacks Investment Research lowered shares of Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. Stifel Nicolaus initiated coverage on shares of Masimo Corporation in a research note on Monday, July 10th. They set a “buy” rating and a $105.00 target price for the company. BidaskClub raised shares of Masimo Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Finally, BTIG Research raised shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Monday, August 14th.

In related news, Director Sanford Fitch sold 11,000 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the completion of the sale, the director now owns 72,249 shares in the company, valued at approximately $6,303,725.25. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Jon Coleman sold 25,000 shares of the company’s stock in a transaction that occurred on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the sale, the insider now owns 32,201 shares of the company’s stock, valued at approximately $3,139,597.50. The disclosure for this sale can be found here. 16.60% of the stock is owned by corporate insiders.

Several large investors have recently modified their holdings of MASI. BlackRock Inc. lifted its position in shares of Masimo Corporation by 7.5% in the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock valued at $721,710,000 after acquiring an additional 550,995 shares in the last quarter. Koch Industries Inc. lifted its position in shares of Masimo Corporation by 5,053.7% in the 2nd quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock valued at $439,000 after acquiring an additional 435,325 shares in the last quarter. State Street Corp lifted its position in shares of Masimo Corporation by 42.8% in the 1st quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock valued at $130,704,000 after acquiring an additional 419,767 shares in the last quarter. Acadian Asset Management LLC lifted its position in shares of Masimo Corporation by 28.0% in the 2nd quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock valued at $163,356,000 after acquiring an additional 392,410 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in shares of Masimo Corporation by 76.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock valued at $73,191,000 after acquiring an additional 347,360 shares in the last quarter. Institutional investors and hedge funds own 83.21% of the company’s stock.

TRADEMARK VIOLATION WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at https://www.dailypolitical.com/2017/10/18/masimo-corporation-masi-receives-97-00-consensus-price-target-from-brokerages.html.

Shares of Masimo Corporation (NASDAQ:MASI) traded up 1.30% on Friday, hitting $86.61. The company had a trading volume of 560,879 shares. The company has a 50-day moving average of $85.41 and a 200 day moving average of $89.87. Masimo Corporation has a 12 month low of $53.78 and a 12 month high of $104.71. The stock has a market cap of $4.50 billion, a PE ratio of 14.20 and a beta of 0.82.

Masimo Corporation (NASDAQ:MASI) last released its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The business had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. During the same period in the prior year, the business earned $0.57 earnings per share. The business’s quarterly revenue was up 11.8% on a year-over-year basis. Analysts anticipate that Masimo Corporation will post $2.80 EPS for the current fiscal year.

About Masimo Corporation

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Analyst Recommendations for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.